Vectalys will attend the AACR Annual Meeting 2016 on April 16th-20th in New Orleans to introduce the next generation of non integrating lentiviral particle for gene editing and immunotherapy applications.
We look forward to sharing with you our new non-integrative MS2-based lentiviral particles for mRNA delivery: a safe and efficient opportunity for gene editing and immunotherapy applications at the American Association for Cancer Research (AACR) annual meeting.
Discover our poster: LentiFlash : Safe and efficient RNA delivery (Poster AACR 2016)
Our staff on site are:
Christine Duthoit, In vivo Models Manager and Adriana Georges, business development manager.
If you would like to set up an appointment date and time prior to the annual meeting, please contact us at firstname.lastname@example.org or by phone +33 5 82 99 11 02.
Looking forward to seeing you there!
The Vectalys Team